Welcome to Our Website
CZ BioMed Corp is a privately held Biotechnology company focuses on discovery, development, and commercialization of a new class of potent genetically engineered common cold virus (RVLYSIS) that selectively kills tumor cells, but not normal cells. With this medical breakthrough potentially will help millions of people worldwide in the fight against cancer.
Why Choose Us
First in class innovations.
A genetically engineered Oncolytic virus (RVLYSIS) that selectively kills tumor cells, but not normal cells.
Safer to use as compared to its wild-type virus.
Targeted virus replication in tumor cells generates thousands of new therapeutic copies, resulting in the oncolysis of cancer cells and release of the new therapeutic copies to target the adjacent cancer cells in the tumor mass. Therapeutic copies also spread within the body to target and attack distant tumor sites.